Cargando…
Reduced Healthcare Resource Utilization in Patients with Opioid Use Disorder in the 12 Months After Initiation of a Prescription Digital Therapeutic
BACKGROUND AND AIMS: reSET-O, an FDA-authorized prescription digital therapeutic (PDT) delivering cognitive behavioral therapy and contingency management to patients with opioid u(®)se disorder (OUD), may help improve clinical outcomes. One-year differences in healthcare resource utilization (HCRU)...
Autores principales: | Velez, Fulton F., Anastassopoulos, Kathryn P., Colman, Samuel, Shah, Neel, Kauffman, Laura, Murphy, Sean M., Ruetsch, Charles, Maricich, Yuri A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402736/ https://www.ncbi.nlm.nih.gov/pubmed/35799080 http://dx.doi.org/10.1007/s12325-022-02217-y |
Ejemplares similares
-
Real-World Reductions in Healthcare Resource Utilization over 6 Months in Patients with Substance Use Disorders Treated with a Prescription Digital Therapeutic
por: Shah, Neel, et al.
Publicado: (2022) -
Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder
por: Velez, Fulton F, et al.
Publicado: (2021) -
Real-World Evaluation of Clinical Response and Long-Term Healthcare Resource Utilization Patterns Following Treatment with a Digital Therapeutic for Chronic Insomnia
por: Forma, Felicia, et al.
Publicado: (2022) -
Cost-Effectiveness Analysis of a Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder
por: Velez, Fulton F., et al.
Publicado: (2021) -
FDA regulations and prescription digital therapeutics: Evolving with the technologies they regulate
por: Watson, Anthony, et al.
Publicado: (2023)